🚚 Free discreet shipping on orders over $199
Semaglutide 2.4mg · FDA-Approved Weight Loss Molecule

WEGOVY

Compounded Semaglutide · Once Weekly Injection · 0.25mg to 2.4mg
✓ Weight-Loss Specific Dose ✓ 5-Step Titration ✓ 15% Avg Body Weight Loss ✓ Cold-Pack Shipping
Select Your Dose
0.25mg
Starter · Weeks 1–4
$349/mo
$1,349 retail
0.5mg
Step 2 · Weeks 5–8
$359/mo
$1,349 retail
1mg
Step 3 · Weeks 9–12
$369/mo
$1,349 retail
1.7mg
Step 4 · Weeks 13–16
$379/mo
$1,349 retail
2.4mg
Maintenance · Week 17+
$399/mo
$1,349 retail
💰 You save $1,000/month vs. retail Wegovy at $1,349
1
📦 Free shipping — arrives in 2–4 business days
❄️ Cold-pack included — maintains cold chain in transit
🔒 Plain brown box — fully discreet packaging
↩️ 30-day money-back guarantee
⚠️ Compounded semaglutide is not an FDA-approved finished drug product. Prepared by a licensed 503A pharmacy. Consult a healthcare provider before use.
About This Medication

WHAT IS WEGOVY?

Wegovy is the weight-loss branded version of semaglutide, developed specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition. While Ozempic tops out at 2mg for diabetes management, Wegovy is titrated to 2.4mg — a higher dose that produces meaningfully greater weight loss outcomes.

FDA-approved for weight management in June 2021, Wegovy became the first GLP-1 medication specifically indicated for obesity treatment in over a decade. It is also approved to reduce the risk of cardiovascular events in adults with obesity and established cardiovascular disease — making it the first weight-loss drug with a proven heart benefit.

In the landmark STEP 1 clinical trial, participants on 2.4mg semaglutide lost an average of 14.9% of their body weight over 68 weeks — more than three times the weight loss seen with placebo. In the 2024 STEP-UP trial studying the higher 7.2mg Wegovy HD dose, participants achieved even greater results.

Wegovy packaging
15%
Average body weight loss in STEP 1 trial over 68 weeks
2.4mg
Standard maintenance dose — highest approved semaglutide dose for weight loss
5
Titration steps from 0.25mg to full maintenance dose
20%
Reduction in major cardiovascular events (SELECT trial)
Wegovy vs Ozempic

HOW WEGOVY DIFFERS FROM OZEMPIC

Both contain semaglutide. The difference is the indicated use and the maximum dose. Ozempic is approved for type 2 diabetes at up to 2mg. Wegovy is approved for chronic weight management and reaches 2.4mg — a 20% higher maintenance dose that produces meaningfully greater appetite suppression and weight loss. If your primary goal is weight loss rather than diabetes management, Wegovy's titration schedule and higher maintenance dose are specifically optimized for that outcome.

FeatureWegovyOzempic
Active ingredientSemaglutideSemaglutide
Primary indicationWeight managementType 2 diabetes
Maximum dose2.4mg/week2mg/week
Titration steps5 steps4 steps
Average weight loss~15%~14%
Cardiovascular benefitFDA approved (SELECT)FDA approved
Our price from$349/mo$299/mo
Complete Dosing Protocol

WEGOVY TITRATION SCHEDULE

Wegovy's 5-step titration takes 16–20 weeks to reach the full 2.4mg maintenance dose. Each step lasts a minimum of 4 weeks. If you experience intolerable side effects at any step, stay at the previous dose for an additional 4 weeks before trying again. The titration schedule cannot be rushed.

StepWeeksDoseWhat to Expect
Step 1Weeks 1–40.25mgTolerance building. Mild nausea possible. Slight appetite reduction. This is not a therapeutic dose for weight loss — do not judge results here.
Step 2Weeks 5–80.5mgAppetite suppression begins. Most patients notice reduced food cravings and smaller portion satisfaction. Expect 3–6 lbs weight loss.
Step 3Weeks 9–121mgSignificant appetite reduction. "Food noise" — the mental preoccupation with eating — quiets substantially. Steady weight loss of 1–2 lbs/week for most patients.
Step 4Weeks 13–161.7mgNear-full therapeutic effect. Many patients stay at this dose long-term if weight loss goals are being met without moving to 2.4mg.
MaintenanceWeek 17+2.4mgStandard maintenance dose. Maximum appetite suppression. Clinical trials ran patients at this dose for 68 weeks. Some patients find 1.7mg sufficient and never need to reach 2.4mg.
⚠️ Titration Rules
Never skip a step or accelerate the schedule. Increasing dose too fast causes severe nausea and vomiting that may require medical attention. If you miss a dose, take it within 5 days — if more than 5 days have passed, skip and resume your normal schedule the following week. Never take two doses in the same week.
Safety Information

SIDE EFFECTS

Common Side Effects Most improve within 4–8 weeks
  • Nausea — affects up to 44% of Wegovy patients in clinical trials. Worst at dose increases. Eating smaller, lower-fat meals significantly reduces severity.
  • Diarrhea — affects approximately 30% of patients. Usually resolves within 4–6 weeks.
  • Vomiting — less common than nausea. Typically occurs within a few hours of injection.
  • Constipation — can alternate with diarrhea in early weeks.
  • Abdominal pain — related to slowed digestion. Usually mild and decreases over time.
  • Headache — especially in the first few weeks.
  • Fatigue — particularly on injection day and the day after.
  • Injection site reactions — redness, bruising, or mild swelling at the injection site.
Serious Side Effects Seek immediate care
  • Thyroid C-cell tumors — FDA boxed warning. Do not use if you or a family member have had medullary thyroid carcinoma or MEN 2.
  • Pancreatitis — severe abdominal pain radiating to the back. Discontinue immediately and seek emergency care.
  • Acute kidney injury — usually from dehydration secondary to vomiting/diarrhea. Stay hydrated especially during dose increases.
  • Gallbladder disease — gallstones and cholecystitis have been reported. Symptoms include right upper abdominal pain and fever.
  • NAION — rare optic nerve condition causing sudden vision loss. Seek emergency care for any sudden vision changes.
  • Hypoglycemia — risk increases if combined with insulin or sulfonylurea medications.
  • Anaphylaxis — rare but serious allergic reaction requiring emergency treatment.
Customer Experiences

REVIEWS

4.9
★★★★★
Based on 248 verified orders
★★★★★
"22 pounds in 10 weeks on Wegovy. I stalled on Ozempic at 2mg for months with no further progress. Switching to the Wegovy titration at 2.4mg made a significant difference. My cravings essentially disappeared."
SK
Sandra K.
Wegovy 2.4mg · 10 Weeks
★★★★★
"I was nervous about the nausea people talk about. Weeks 1 and 2 I felt a bit off but by week 3 I was completely fine. Now at 1.7mg and down 31 lbs over 4 months. Will probably stay at 1.7 — I don't need to go to 2.4 at this rate."
DP
Donna P.
Wegovy 1.7mg · 4 Months
★★★★★
"The packaging is genuinely discreet. Just a plain box. Medication was cold when it arrived. I've ordered 4 times now and every order has been perfect. The savings vs what I was paying at the pharmacy are enormous."
MH
Michelle H.
Wegovy 2.4mg · 6 Months
Questions Answered

WEGOVY FAQ

What is the difference between Wegovy and compounded semaglutide at 2.4mg? +
Brand-name Wegovy is manufactured by Novo Nordisk, FDA-approved, and sold at ~$1,349/month. Compounded semaglutide at 2.4mg uses the same active molecule prepared by a licensed 503A pharmacy. The active ingredient is chemically identical. The compounded version is not manufactured by Novo Nordisk, is not FDA-approved as a finished product, and costs significantly less.
Do I need to reach 2.4mg to get results? +
No. Many patients achieve significant weight loss at 1mg or 1.7mg and never need to reach 2.4mg. The goal is to find the lowest dose that produces satisfactory weight loss with tolerable side effects. In clinical practice, a significant proportion of patients remain at 1.7mg long-term.
How long does it take to reach the 2.4mg maintenance dose? +
The standard Wegovy titration takes 16 weeks (4 months) to reach 2.4mg following the 5-step schedule at 4 weeks per step. If you need extra time at any step due to side effects, the full titration can take 20 weeks or longer. This is perfectly normal and safe.
Can I take Wegovy if I'm not diabetic? +
Yes. Unlike Ozempic (which is approved for type 2 diabetes), Wegovy was specifically approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. You do not need a diabetes diagnosis.
What happens if I regain weight after stopping? +
Weight regain after stopping semaglutide is common and well-documented. The STEP 4 trial found that patients who stopped Wegovy after a period of successful weight loss regained approximately two-thirds of their lost weight within 12 months. This indicates that semaglutide works best as a long-term treatment rather than a short-term intervention.
Related Medications

YOU MAY ALSO CONSIDER

WhatsApp Telegram +1 217 681 4147